Responses
Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
206 Validation of NanoString® technologies for solid tumor clinical studies: robustness, precision and inter-site comparison
Compose a Response to This Article
Other responses
No responses have been published for this article.
